Biomobie

Biomobie Corp., USA, located in Silicon Valley, and its sister company Biomobie (Shanghai) Regenerative Medicine Technology Co., Ltd. are leading regenerative medicine technology companies. Biomobie focuses on regenerative rehabilitation for patients with cardiovascular, cerebrovascular, and neurological disorders. Its product line Bioboosti covers regenerative repair for chronic conditions such as hypertension, sleep disorders, cardiac blood supply, arthritis, stroke, and digestive system dysfunction. Biomobie Corp., USA is the product design center of the Bioboosti Life Nuclear Power R&D Center. Biomobie (Shanghai) Regenerative Medicine Technology Co., Ltd. serves as the production and quality center for Bioboosti life nuclear products. The Biomobie (Shanghai) Regenerative Medicine Operations Center officially opened in 2014. The three companies under the Biomobie brand are held by Biomobie Holdings and invested and established by Master Global Investments. Bioboosti Life Nuclear has undergone 10 years of basic research, dozens of cellular and animal experiments, and thousands of volunteer human trials lasting up to 5 years. The Biomobie Regenerative Medicine Center is the first vascular regeneration rehabilitation center in China, located in the new landmark of Shanghai Hongqiao Development Zone - the Summit Center. The center is dedicated to providing the most advanced cardiovascular and cerebrovascular rehabilitation solutions, representing a brand-new life regeneration medical system after traditional Chinese medicine and Western medicine, and embodies advanced preventive medicine.